Source: FOX News
Summary
GLP-1s, or glucagon-like peptide-1 receptor agonists, have gained popularity for weight loss and metabolic health. Some users microdose the drug, taking small amounts, but experts warn against it. Dr. Terry Dubrow recommends a low daily dose, even for those who don’t need to lose weight. However, Dr. Andre Teixeira, a bariatric surgeon, claims microdosing is “truly dependent” on the individual and can be more expensive in the long run. He recommends working closely with a healthcare provider before starting a GLP-1.
Our Reading
The advice sounds familiar.
GLP-1s have become the latest trend in weight loss and metabolic health, with some users microdosing the drug. However, experts are divided on the effectiveness and safety of this approach. While some claim it’s a “legit longevity drug,” others warn of potential side effects and lack of a true protocol. As with any health trend, it’s essential to approach with caution and consult with a healthcare provider.
It seems like every few years, a new “miracle” drug or treatment emerges, only to be followed by warnings and controversy.
Author: Evan Null
